Financial Performance - For the fiscal year ending March 31, 2024, the company's revenue increased by approximately 6.8% to about HKD 81.9 million from approximately HKD 76.7 million for the previous year[10]. - Gross profit rose by approximately HKD 2.4 million or 6.1% to about HKD 41.9 million, while the gross profit margin slightly decreased from 51.5% to 51.2%[11]. - The group's profit increased from approximately HKD 7,600,000 for the year ended March 31, 2023, to approximately HKD 7,800,000 for the year ended March 31, 2024, representing an increase of about 2.63%[15]. - Income tax expense for the fiscal year was approximately HKD 400,000, a decrease from HKD 1.8 million in the previous year, attributed to tax planning strategies adopted by the company[13]. - The board declared an interim dividend of HKD 0.25 per ordinary share for the year ending March 31, 2024, down from HKD 0.4 in 2023[16]. Business Expansion and Strategy - The company established a joint venture to promote the development of autonomous mobile robot solutions in the healthcare sector, supporting business growth and expansion[9]. - A non-wholly owned subsidiary was set up in Macau with a registered capital of MOP 50,000, with an estimated investment cost of approximately HKD 300,000 to expand business in that region[9]. - The company is actively seeking suitable investment opportunities to diversify its business and enhance shareholder returns[6]. - The overall economic environment in Hong Kong is stabilizing post-COVID-19, contributing to the recovery of medical equipment revenues[10]. - The company is exploring market expansion opportunities in D regions, targeting a market penetration increase of E%[45]. Workforce and Employee Development - The group has expanded its workforce, hiring seven product representatives, two engineers, and other staff, increasing total employees to 46 from 41 in 2023[31]. - Overall attrition rate for the group increased to 32.2% in FY2024 from 19.5% in FY2023[177]. - The average training hours per employee decreased to 7.5 hours in FY2024 from 9.0 hours in FY2023[190]. - Approximately 40% of the middle management team is female, reflecting the company's commitment to diversity and equal opportunity[183]. - The group has implemented a transparent recruitment process based on skills, qualifications, and performance[180]. Corporate Governance - The company has adopted the principles and code provisions of the corporate governance code as per GEM Listing Rules Appendix C1, ensuring compliance with all provisions except for one[56]. - The board consists of six members, including the Chairperson and CEO, with a balanced composition in terms of age, gender, and tenure[63][67]. - The company emphasizes a culture of integrity and commitment to ethical standards, which is reflected in its training materials and employee handbook[57][58]. - The company has established three board committees: the audit committee, remuneration committee, and nomination committee, to enhance governance[72]. - The independent non-executive directors have confirmed their independence annually, aligning with GEM listing rules[68]. Environmental, Social, and Governance (ESG) Initiatives - The company is committed to sustainable development, integrating environmental, social, and governance (ESG) principles into its business strategy[131]. - The board reviews ESG performance at least annually and adjusts management methods as necessary[134]. - The group has conducted a materiality assessment to identify significant ESG issues, which will guide the preparation of the ESG report[140]. - The group has set a target to maintain or reduce the total harmless waste density from the FY2022 baseline of approximately 11.86 kg per million revenue by FY2030[160]. - The group encourages stakeholder feedback on its ESG policies and performance to enhance sustainable development efforts[149]. Risk Management and Compliance - The group has established risk management policies to identify, assess, and manage key business risks, with management responsible for overseeing these activities[106]. - The company has implemented a robust internal control system to manage risks and ensure compliance with regulatory requirements[67]. - The group has adopted a whistleblowing policy to promote compliance and ethical behavior, with no significant fraud or misconduct reported for the fiscal year ending March 31, 2024[108]. - The company has implemented an insider information disclosure policy to ensure timely and appropriate disclosure of sensitive information[112]. - The board believes that the group's risk management and internal control systems are effective and adequate, with no significant deficiencies identified[107].
君百延集团(08372) - 2024 - 年度财报